USE OF SR-90 IN THE TREATMENT OF CARCINOMA INSITU OF THE CONJUNCTIVA

被引:33
作者
ELKON, D [1 ]
CONSTABLE, WC [1 ]
机构
[1] UNIV VIRGINIA HOSP,DEPT RADIAT ONCOL,CHARLOTTESVILLE,VA 22901
关键词
D O I
10.1016/0002-9394(79)90196-X
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Four patients with carcinoma in situ were treated with strontium-90 beta ray application. The dose used was 4,500 rads after surgical removal or with small recurrent tumor and 7,000 rads for primary treatment. All patients were disease-free at follow-up periods of 48 to 320 months after treatment. One patient required superficial x-ray treatment for recurrent disease. No serious complications developed with the treatment and no progressive cataracts have occurred. © 1979.
引用
收藏
页码:84 / 86
页数:3
相关论文
共 15 条
[1]  
Ash JE, 1942, AM J OPHTHALMOL, V25, P926, DOI [DOI 10.1016/S0002-9394(42)90592-0, 10.1016/S0002-9394(42)90592-0]
[2]  
CARROLL JM, 1965, ARCH OPHTHALMOL-CHIC, V73, P545
[3]  
FLETCHER GH, 1973, TXB RADIOTHERAPY, P449
[4]  
HUGHES WF, 1959, JAMA, P2096
[5]  
Irvine A R, 1963, Trans Am Ophthalmol Soc, V61, P243
[7]   BETA-RAY TREATMENT OF MALIGNANT EPITHELIAL TUMORS OF CONJUNCTIVA [J].
LOMMATZSCH, P .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1976, 81 (02) :198-206
[8]   OCULAR COMPLICATIONS AFTER THERAPEUTIC IRRADIATION [J].
MACFAUL, PA ;
BEDFORD, MA .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1970, 54 (04) :237-&
[9]  
MCDONALD JE, 1959, T AM ACAD OPHTHALMOL, V64, P468
[10]  
Merriam GR., 1972, FRONT RAD THER ONCOL, P346